NO20032769L - Kombinasjonsmetode for behandling av virale infeksjoner - Google Patents

Kombinasjonsmetode for behandling av virale infeksjoner

Info

Publication number
NO20032769L
NO20032769L NO20032769A NO20032769A NO20032769L NO 20032769 L NO20032769 L NO 20032769L NO 20032769 A NO20032769 A NO 20032769A NO 20032769 A NO20032769 A NO 20032769A NO 20032769 L NO20032769 L NO 20032769L
Authority
NO
Norway
Prior art keywords
treatment
viral infections
combination method
combination
infections
Prior art date
Application number
NO20032769A
Other languages
English (en)
Norwegian (no)
Other versions
NO20032769D0 (no
Inventor
Bahige M Baroudy
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20032769D0 publication Critical patent/NO20032769D0/no
Publication of NO20032769L publication Critical patent/NO20032769L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
NO20032769A 2000-12-19 2003-06-18 Kombinasjonsmetode for behandling av virale infeksjoner NO20032769L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25665700P 2000-12-19 2000-12-19
PCT/US2001/048802 WO2002056902A2 (en) 2000-12-19 2001-12-17 Ccr5 antagonist and dp-178 polypeptide for treating viral infections

Publications (2)

Publication Number Publication Date
NO20032769D0 NO20032769D0 (no) 2003-06-18
NO20032769L true NO20032769L (no) 2003-08-18

Family

ID=22973061

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032769A NO20032769L (no) 2000-12-19 2003-06-18 Kombinasjonsmetode for behandling av virale infeksjoner

Country Status (12)

Country Link
US (1) US20050065319A1 (enExample)
EP (1) EP1385534A2 (enExample)
JP (1) JP2005500981A (enExample)
CN (1) CN1481251A (enExample)
AR (1) AR031931A1 (enExample)
BR (1) BR0116253A (enExample)
CA (1) CA2431919A1 (enExample)
HU (1) HUP0302241A3 (enExample)
MX (1) MXPA03005526A (enExample)
NO (1) NO20032769L (enExample)
WO (1) WO2002056902A2 (enExample)
ZA (1) ZA200304560B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2400553A (en) * 2003-04-14 2004-10-20 Cipla Ltd Antiviral pharmaceutical combination of lamivudine, stavudine and efavirenz, or derivatives thereof
BRPI0410360A (pt) * 2003-05-16 2006-08-01 Univ Maryland Biotech Inst composições para a sub-regulação da expressão de ccr5 e métodos para seu uso
CA2587903A1 (en) 2004-11-17 2006-05-26 Amgen Fremont Inc. Fully human monoclonal antibodies to il-13
JP2009517474A (ja) * 2005-11-30 2009-04-30 シェーリング コーポレイション Ｃｃｒ５拮抗剤およびｃｘｃｒ４拮抗剤の組み合わせを含む組成物
EP1976497A2 (en) * 2005-12-01 2008-10-08 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Treatment of viral infections
EP1886696A1 (en) * 2006-08-03 2008-02-13 Endotis Pharma Conjugates of antithrombin binding oligosaccharide derivatives and therapeutic proteins
WO2013127299A1 (zh) * 2012-02-28 2013-09-06 中国人民解放军军事医学科学院毒物药物研究所 用于抑制hiv的多肽及其作用靶点
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
CA2224008C (en) * 1995-06-07 2009-08-18 Trimeris, Inc. The treatment of hiv and other viral infections using combinatorial therapy
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
CA2365900A1 (en) * 1999-05-04 2000-11-09 Schering Corporation Pegylated interferon alfa-ccr5 antagonist combination hiv therapy
US6391865B1 (en) * 1999-05-04 2002-05-21 Schering Corporation Piperazine derivatives useful as CCR5 antagonists
US6689765B2 (en) * 1999-05-04 2004-02-10 Schering Corporation Piperazine derivatives useful as CCR5 antagonists
PT1175402E (pt) * 1999-05-04 2005-11-30 Schering Corp Derivados da piperidina uteis como antagonistas ccr5
US6387930B1 (en) * 1999-05-04 2002-05-14 Schering Corporation Piperidine derivatives useful as CCR5 antagonists

Also Published As

Publication number Publication date
HUP0302241A2 (hu) 2003-11-28
US20050065319A1 (en) 2005-03-24
WO2002056902A3 (en) 2002-12-05
WO2002056902A2 (en) 2002-07-25
CA2431919A1 (en) 2002-07-25
ZA200304560B (en) 2005-07-27
BR0116253A (pt) 2006-05-02
MXPA03005526A (es) 2003-10-06
EP1385534A2 (en) 2004-02-04
CN1481251A (zh) 2004-03-10
JP2005500981A (ja) 2005-01-13
HUP0302241A3 (en) 2005-06-28
NO20032769D0 (no) 2003-06-18
AR031931A1 (es) 2003-10-08

Similar Documents

Publication Publication Date Title
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
PL376454A1 (en) 1-acyl-pyrrolidine derivatives for the treatment of viral infections
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
NO20031615L (no) Pyrazol-derivater for behandling av virus-sykdommer
DE60136477D1 (de) Retinoide zur behandlung von emphysem
NO20040253L (no) Fremgangsmater for behandling av leverfibroser
NO20023482D0 (no) Fremgangsmåte for behandling av stoffmisbruk
NO20040027L (no) Fremgangsmate for fremstillingen av escitalopram
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
DE60227963D1 (de) Behandlungssystem
FI20012170A0 (fi) Menetelmä lauhteiden käsittelemiseksi
NO20026219L (no) Forbindelser for behandling av svekket fundisk relaksasjon
NO20035538D0 (no) Fremgangsmåte for fremstilling av zaleplon
PT1220858E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes virais
NO20022816D0 (no) Behandling av virale infeksjoner ved anvendelse av Levovirin
NO20040087L (no) Fremgangsmate for behandling av sovnloshet
NO20032769L (no) Kombinasjonsmetode for behandling av virale infeksjoner
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
NO20012541D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
DE60140597D1 (de) Vakuumbehandlungsverfahren
DK1200447T3 (da) Oxazinocarbazoler til behandling af CNS-sygdomme
NO20022253L (no) Middel til behandling av hepatitt C

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application